Ovation wins FDA advisers' support for seizure medicine

01/7/2009 | Chicago Tribune (tiered subscription model)

An FDA advisory panel unanimously endorsed approval of Sabril, a seizure medication from Ovation Pharmaceuticals, as adjunct therapy for patients who do not respond to other anti-epileptic treatments. Ovation plans to market Sabril for adults with refractory complex partial seizures.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN